Nifty
:
24273.80
Sensex
:
80334.81
-140.60 (-0.58%)
-411.97 (-0.51%)
Nifty
Sensex
:
:
24273.80
80334.81
-140.60 (-0.58%)
-411.97 (-0.51%)

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: 530549 | NSE: SHILPAMED

NSE BSE
752.60
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  740.45
  •  764.60
  •  737.75
  •  739.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  177528
  •  1341.69
  •  959.50
  •  417.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,235.15
  • 70.62
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,707.02
  • N/A
  • 2.64

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.23%
  • 10.83%
  • 24.42%
  • FII
  • DII
  • Others
  • 10.97%
  • 6.13%
  • 3.42%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.49
  • 4.87
  • 0.18

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.44
  • 1.93
  • 3.66

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -8.04
  • -27.26
  • -19.30

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.18
  • 56.80
  • 69.73

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.70
  • 2.36
  • 2.11

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.48
  • 22.73
  • 22.94

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
3.67
9.05
21.35
63.6
P/E Ratio
243.75
98.85
41.9
14.07
Revenue
310
1354
1709
2672
EBITDA
245
330
514
965
Net Income
32
89
208
622
ROA
1.1
P/B Ratio
4.29
3.58
3.12
2.55
ROE
1.77
4.3
8.25
19.9
FCFF
-140.21
35.4
165.47
437.62
FCFF Yield
-1.46
0.37
1.73
4.57

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
319.32
286.76
11.35%
343.80
312.98
9.85%
292.51
260.18
12.43%
291.69
263.56
10.67%
Expenses
238.62
220.53
8.20%
257.79
252.68
2.02%
218.91
212.26
3.13%
221.63
225.34
-1.65%
EBITDA
80.69
66.23
21.83%
86.01
60.30
42.64%
73.60
47.92
53.59%
70.06
38.23
83.26%
EBIDTM
25.27%
23.09%
25.02%
19.27%
25.16%
18.42%
24.02%
14.50%
Other Income
1.13
1.94
-41.75%
4.99
1.81
175.69%
9.44
1.93
389.12%
2.49
2.17
14.75%
Interest
11.75
26.22
-55.19%
25.55
23.24
9.94%
23.74
18.15
30.80%
24.20
17.74
36.41%
Depreciation
28.81
26.71
7.86%
28.28
27.79
1.76%
27.11
26.75
1.35%
26.63
25.69
3.66%
PBT
41.27
15.23
170.98%
37.16
11.08
235.38%
32.20
4.95
550.51%
27.85
-3.03
-
Tax
9.83
9.46
3.91%
18.83
7.60
147.76%
14.62
2.11
592.89%
3.21
3.82
-15.97%
PAT
31.44
5.77
444.89%
18.33
3.48
426.72%
17.58
2.84
519.01%
24.64
-6.85
-
PATM
9.85%
2.01%
5.33%
1.11%
6.01%
1.09%
8.45%
-2.60%
EPS
3.25
0.53
513.21%
1.83
0.19
863.16%
1.44
0.14
928.57%
2.82
-0.93
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,247.32
1,151.60
1,050.11
1,145.52
901.13
907.91
733.39
788.83
779.16
716.43
613.80
Net Sales Growth
11.02%
9.66%
-8.33%
27.12%
-0.75%
23.80%
-7.03%
1.24%
8.76%
16.72%
 
Cost Of Goods Sold
402.87
407.24
416.04
383.22
270.73
277.73
257.03
355.87
371.81
366.19
323.16
Gross Profit
844.45
744.36
634.07
762.30
630.40
630.18
476.36
432.95
407.36
350.25
290.63
GP Margin
67.70%
64.64%
60.38%
66.55%
69.96%
69.41%
64.95%
54.89%
52.28%
48.89%
47.35%
Total Expenditure
936.95
915.53
961.84
948.32
729.43
693.39
579.39
637.60
617.55
556.44
487.38
Power & Fuel Cost
-
52.41
56.79
52.43
40.25
38.76
33.57
28.86
26.30
21.90
19.29
% Of Sales
-
4.55%
5.41%
4.58%
4.47%
4.27%
4.58%
3.66%
3.38%
3.06%
3.14%
Employee Cost
-
281.49
286.39
264.49
235.31
196.59
176.40
149.35
127.87
90.09
82.30
% Of Sales
-
24.44%
27.27%
23.09%
26.11%
21.65%
24.05%
18.93%
16.41%
12.57%
13.41%
Manufacturing Exp.
-
82.69
110.32
124.11
91.29
79.19
61.23
59.96
52.55
45.35
36.55
% Of Sales
-
7.18%
10.51%
10.83%
10.13%
8.72%
8.35%
7.60%
6.74%
6.33%
5.95%
General & Admin Exp.
-
44.36
46.86
71.58
47.71
70.26
27.20
22.50
16.95
14.11
10.64
% Of Sales
-
3.85%
4.46%
6.25%
5.29%
7.74%
3.71%
2.85%
2.18%
1.97%
1.73%
Selling & Distn. Exp.
-
20.91
18.56
18.02
18.63
10.40
6.72
6.37
4.75
7.27
5.99
% Of Sales
-
1.82%
1.77%
1.57%
2.07%
1.15%
0.92%
0.81%
0.61%
1.01%
0.98%
Miscellaneous Exp.
-
26.42
26.89
34.49
25.51
20.47
17.23
14.68
17.32
11.54
5.99
% Of Sales
-
2.29%
2.56%
3.01%
2.83%
2.25%
2.35%
1.86%
2.22%
1.61%
1.54%
EBITDA
310.36
236.07
88.27
197.20
171.70
214.52
154.00
151.23
161.61
159.99
126.42
EBITDA Margin
24.88%
20.50%
8.41%
17.21%
19.05%
23.63%
21.00%
19.17%
20.74%
22.33%
20.60%
Other Income
18.05
16.59
31.41
20.90
40.09
22.22
15.56
32.62
29.34
11.36
6.93
Interest
85.24
91.81
58.65
41.17
21.87
4.56
3.68
2.66
3.13
3.93
4.05
Depreciation
110.83
107.87
95.50
79.80
53.98
43.78
42.06
37.22
30.64
23.14
21.41
PBT
138.48
52.99
-34.47
97.13
135.95
188.40
123.82
143.96
157.17
144.28
107.89
Tax
46.49
22.39
-7.36
41.68
48.85
33.49
26.18
33.91
42.04
35.62
35.22
Tax Rate
33.57%
37.87%
21.35%
39.35%
24.82%
17.78%
18.22%
23.56%
27.54%
25.11%
32.66%
PAT
91.99
31.88
-32.48
60.66
147.78
156.50
120.28
112.43
113.71
109.84
73.69
PAT before Minority Interest
91.98
31.96
-30.92
60.58
146.20
154.91
117.52
110.05
110.59
106.24
72.62
Minority Interest
-0.01
-0.08
-1.56
0.08
1.58
1.59
2.76
2.38
3.12
3.60
1.07
PAT Margin
7.38%
2.77%
-3.09%
5.30%
16.40%
17.24%
16.40%
14.25%
14.59%
15.33%
12.01%
PAT Growth
1,655.53%
-
-
-58.95%
-5.57%
30.11%
6.98%
-1.13%
3.52%
49.06%
 
EPS
9.41
3.26
-3.32
6.20
15.11
16.00
12.30
11.50
11.63
11.23
7.53

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
1,808.69
1,783.28
1,822.19
1,478.67
1,329.36
1,197.58
1,085.03
986.90
639.26
546.94
Share Capital
8.68
8.68
8.68
8.15
8.15
8.15
8.15
8.01
7.71
7.71
Total Reserves
1,800.01
1,774.60
1,813.51
1,470.51
1,321.21
1,189.43
1,076.88
978.88
631.55
539.23
Non-Current Liabilities
589.64
345.12
452.82
561.37
256.94
166.62
153.48
251.26
67.23
154.15
Secured Loans
560.16
242.92
353.49
473.87
164.48
80.39
67.09
141.20
0.03
71.03
Unsecured Loans
0.00
45.90
0.11
0.35
0.53
0.70
1.03
1.30
0.00
31.30
Long Term Provisions
22.43
17.65
19.08
15.48
26.17
21.77
20.32
16.89
13.96
11.75
Current Liabilities
693.35
784.45
611.54
543.29
410.82
253.44
265.84
236.90
222.07
189.06
Trade Payables
174.82
142.80
146.04
67.25
92.55
80.72
103.74
111.86
106.48
75.50
Other Current Liabilities
137.21
276.56
240.13
219.33
142.10
81.62
59.59
28.03
36.49
49.32
Short Term Borrowings
360.73
344.17
202.90
243.40
165.27
86.58
98.12
92.41
74.10
58.47
Short Term Provisions
20.58
20.92
22.46
13.31
10.89
4.52
4.39
4.60
5.00
5.77
Total Liabilities
3,082.94
2,903.93
2,875.50
2,572.16
1,989.21
1,610.02
1,499.13
1,472.22
930.89
904.54
Net Block
1,384.86
1,368.33
1,341.84
1,110.53
650.44
558.01
534.20
491.93
393.41
316.06
Gross Block
1,946.75
1,846.68
1,727.09
1,421.10
986.42
853.16
793.24
704.89
582.20
476.34
Accumulated Depreciation
561.89
478.35
385.25
310.57
335.98
295.15
259.04
212.96
188.79
160.28
Non Current Assets
2,206.12
2,134.37
1,988.30
1,729.60
1,365.35
1,064.96
827.16
742.33
576.68
576.77
Capital Work in Progress
718.78
655.33
506.18
541.29
666.25
429.12
209.85
140.51
91.90
221.62
Non Current Investment
39.91
42.66
34.23
21.22
10.45
2.25
20.79
27.99
34.15
0.19
Long Term Loans & Adv.
53.32
56.53
93.90
43.10
32.42
48.75
37.47
77.09
51.86
38.74
Other Non Current Assets
9.25
11.52
12.15
13.46
5.78
26.84
24.86
4.80
5.36
0.16
Current Assets
876.83
769.55
887.19
818.99
623.85
545.06
671.97
729.88
354.21
327.61
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
119.54
224.62
59.63
65.35
Inventories
344.93
319.82
355.24
316.84
226.43
187.67
188.71
190.00
134.23
130.78
Sundry Debtors
392.05
324.35
386.33
217.50
246.79
203.73
220.27
170.93
125.43
81.37
Cash & Bank
30.44
21.56
34.11
123.11
44.56
94.54
73.83
100.39
11.03
18.42
Other Current Assets
109.42
15.53
9.36
98.73
106.06
59.12
69.62
43.95
23.90
31.69
Short Term Loans & Adv.
90.60
88.29
102.16
62.81
29.25
14.08
43.54
21.95
8.90
4.91
Net Current Assets
183.48
-14.89
275.66
275.69
213.04
291.62
406.13
492.98
132.14
138.55
Total Assets
3,082.95
2,903.92
2,875.49
2,548.59
1,989.20
1,610.02
1,499.13
1,472.21
930.89
904.54

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
135.34
179.92
105.13
46.93
124.38
146.78
44.92
37.48
128.70
68.81
PBT
54.34
-38.28
102.26
196.79
188.40
143.70
136.77
146.49
140.36
107.84
Adjustment
205.77
147.81
109.34
4.03
41.32
20.44
18.83
17.19
20.61
26.46
Changes in Working Capital
-83.62
102.77
-71.99
-106.29
-63.15
18.71
-69.66
-92.61
-2.70
-40.11
Cash after chg. in Working capital
176.49
212.30
139.62
94.53
166.57
182.85
85.94
71.08
158.27
94.19
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-41.15
-32.37
-34.48
-47.60
-42.20
-36.07
-41.02
-33.60
-29.56
-25.38
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-166.58
-232.61
-285.50
-404.28
-289.52
-196.16
-8.76
-262.23
-109.20
-195.18
Net Fixed Assets
-17.18
-22.18
384.16
-272.02
-4.28
-256.96
-136.75
-172.23
-92.14
-78.46
Net Investments
-2.53
-6.42
-18.18
-125.84
-4.44
141.85
95.51
-172.72
-14.09
-64.38
Others
-146.87
-204.01
-651.48
-6.42
-280.80
-81.05
32.48
82.72
-2.97
-52.34
Cash from Financing Activity
46.77
45.80
82.86
436.37
175.50
10.06
-60.91
312.70
-19.65
135.05
Net Cash Inflow / Outflow
15.53
-6.89
-97.51
79.03
10.36
-39.32
-24.75
87.95
-0.15
8.68
Opening Cash & Equivalents
19.07
25.62
122.85
44.31
34.13
73.83
99.97
7.05
3.61
9.19
Closing Cash & Equivalent
30.43
19.07
25.34
123.34
44.31
34.36
73.83
99.97
6.43
18.42

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
208.37
205.44
209.93
181.37
163.06
146.89
133.09
123.17
82.91
70.92
ROA
1.07%
-1.07%
2.20%
6.33%
8.61%
7.56%
7.41%
9.20%
11.58%
9.18%
ROE
1.78%
-1.71%
3.67%
10.41%
12.26%
10.30%
10.62%
13.60%
17.92%
15.40%
ROCE
5.49%
0.80%
5.94%
10.73%
12.41%
11.05%
11.71%
15.91%
19.90%
17.90%
Fixed Asset Turnover
0.61
0.59
0.73
0.75
0.99
0.89
1.06
1.22
1.36
1.34
Receivable days
113.53
123.51
98.75
94.03
90.56
105.51
90.20
69.00
52.26
43.99
Inventory Days
105.35
117.32
109.68
110.03
83.24
93.66
87.32
75.49
66.97
74.84
Payable days
142.34
126.70
106.00
107.72
47.69
58.00
61.51
60.89
60.10
62.86
Cash Conversion Cycle
76.54
114.12
102.43
96.33
126.11
141.17
116.00
83.61
59.13
55.97
Total Debt/Equity
0.52
0.45
0.37
0.57
0.29
0.16
0.18
0.24
0.14
0.34
Interest Cover
1.59
0.35
3.48
9.92
42.34
40.09
55.10
49.69
37.07
27.63

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Shilpa Medicare receives GMP approval from European Medicines Agency
    6th May 2025, 12:59 PM

    The company has received GMP approval for its Unit VI located at Bengaluru, Karnataka

    Read More
  • Shilpa Medicare gets USFDA’s approval for Varenicline Tablets
    9th Apr 2025, 17:12 PM

    The total US market for this product is around $203 million.

    Read More
  • Shilpa Medicare’s marketing partner launches BORUZU in US market
    3rd Apr 2025, 15:40 PM

    The product has already been granted permanent J-code by U.S. Centers for Medicare & Medicaid Services

    Read More
  • USFDA concludes inspection at Unit-2 of Shilpa Medicare’s arm in Raichur
    15th Mar 2025, 15:36 PM

    The inspection was closed with ZERO observations

    Read More
  • USFDA concludes inspection at Unit-1 of Shilpa Medicare’s arm in Raichur
    8th Mar 2025, 11:48 AM

    On conclusion of inspection, the company received 1 observation in form 483, which is procedural in nature

    Read More
  • Shilpa Medicare - Quarterly Results
    10th Feb 2025, 14:31 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.